Cencora (COR) Stock: Charts & Financials

Cencora, Inc. (COR)CORCencora, Inc.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA

51,000 employees

www.cencora.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Robert Mauch

View full financials

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	53.14B	53.14B	54.15B	52.24B	48.81B	46.53B	49.99B	47.72B	47.31B
Cash & Cash Equivalents	2.24B	2.24B	1.81B	4.39B	2.28B	2.11B	3.33B	3.23B	3.41B
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	2.24B	2.24B	1.81B	4.39B	2.28B	2.11B	3.33B	3.23B	3.41B
Accounts Receivable	24.89B	24.89B	25.98B	25.23B	24.56B	23.72B	24.55B	23.87B	24.05B
Inventory	20.01B	20.01B	24.08B	20.49B	20.14B	18.97B	20.51B	19.00B	18.30B
Total Assets	81.65B	81.65B	78.36B	76.59B	73.96B	71.19B	69.05B	67.10B	66.77B
Property, Plant & Equipment	2.81B	2.81B	2.45B	4.09B	2.43B	2.30B	2.10B	3.32B	2.08B
Goodwill	16.45B	16.45B	13.73B	13.68B	14.33B	14.09B	9.18B	9.32B	9.61B
Intangible Assets	6.05B	6.05B	3.68B	3.77B	3.93B	3.86B	3.68B	4.00B	4.01B
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	68.21M	67.46M	66.64M	104.46M
Total Current Liabilities	56.13B	56.13B	59.13B	57.82B	53.96B	53.33B	54.51B	54.28B	52.97B
Accounts Payable	51.88B	51.88B	56.06B	54.72B	51.04B	50.11B	49.91B	50.94B	49.88B
Short-Term Debt	202.66M	202.66M	342.28M	371.56M	196.79M	770.32M	2.21B	781.10M	565.11M
Total Liabilities	78.07B	78.07B	76.27B	74.84B	71.75B	70.01B	68.69B	66.31B	65.71B
Long-Term Debt	12.18B	12.18B	7.58B	8.96B	8.04B	7.09B	5.94B	4.84B	4.17B
Total Debt	12.39B	12.39B	7.92B	10.75B	8.24B	7.86B	8.15B	6.65B	4.73B
Net Debt (Cash)	10.15B	10.15B	6.11B	6.35B	5.97B	5.75B	4.82B	3.42B	1.32B
Total Shareholders' Equity	3.40B	3.40B	1.91B	1.51B	1.98B	1.01B	226.58M	645.94M	925.21M
Common Stock	2.98M	2.98M	2.98M	2.97M	2.97M	2.97M	2.97M	2.96M	2.96M
Retained Earnings	8.49B	8.49B	6.97B	6.53B	6.98B	6.40B	5.79B	5.42B	5.51B
Current Ratio	0.95	0.95	0.92	0.90	0.90	0.87	0.92	0.88	0.89
Debt to Equity Ratio	3.65	3.65	4.15	7.13	4.16	7.76	35.96	10.30	5.11

Quarterly Report

TTM

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Quarter ended Jun 2024

Total Current Assets

53.14B

54.15B

52.24B

48.81B

46.53B

49.99B

47.72B

47.31B

Cash & Cash Equivalents

2.24B

1.81B

4.39B

2.28B

2.11B

3.33B

3.23B

3.41B

Short-Term Investments

0.00

Cash & Short-Term Investments

2.24B

1.81B

4.39B

2.28B

2.11B

3.33B

3.23B

3.41B

Accounts Receivable

24.89B

25.98B

25.23B

24.56B

23.72B

24.55B

23.87B

24.05B

Inventory

20.01B

24.08B

20.49B

20.14B

18.97B

20.51B

19.00B

18.30B

Total Assets

81.65B

78.36B

76.59B

73.96B

71.19B

69.05B

67.10B

66.77B

Property, Plant & Equipment

2.81B

2.45B

4.09B

2.43B

2.30B

2.10B

3.32B

2.08B

Goodwill

16.45B

13.73B

13.68B

14.33B

14.09B

9.18B

9.32B

9.61B

Intangible Assets

6.05B

3.68B

3.77B

3.93B

3.86B

3.68B

4.00B

4.01B

Long-Term Investments

0.00

68.21M

67.46M

66.64M

104.46M

Total Current Liabilities

56.13B

59.13B

57.82B

53.96B

53.33B

54.51B

54.28B

52.97B

Accounts Payable

51.88B

56.06B

54.72B

51.04B

50.11B

49.91B

50.94B

49.88B

Short-Term Debt

202.66M

342.28M

371.56M

196.79M

770.32M

2.21B

781.10M

565.11M

Total Liabilities

78.07B

76.27B

74.84B

71.75B

70.01B

68.69B

66.31B

65.71B

Long-Term Debt

12.18B

7.58B

8.96B

8.04B

7.09B

5.94B

4.84B

4.17B

Total Debt

12.39B

7.92B

10.75B

8.24B

7.86B

8.15B

6.65B

4.73B

Net Debt (Cash)

10.15B

6.11B

6.35B

5.97B

5.75B

4.82B

3.42B

1.32B

Total Shareholders' Equity

3.40B

1.91B

1.51B

1.98B

1.01B

226.58M

645.94M

925.21M

Common Stock

2.98M

2.97M

2.96M

Retained Earnings

8.49B

6.97B

6.53B

6.98B

6.40B

5.79B

5.42B

5.51B

Current Ratio

0.95

0.92

0.90

0.87

0.92

0.88

0.89

Debt to Equity Ratio

3.65

4.15

7.13

4.16

7.76

35.96

10.30

5.11

Annual Report	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021	09/30/2020	09/30/2019	09/30/2018
Total Current Assets	52.24B	47.72B	42.80B	39.59B	38.80B	33.02B	28.13B	25.89B
Cash & Cash Equivalents	4.39B	3.23B	2.69B	3.53B	2.55B	4.60B	3.37B	2.49B
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	4.39B	3.23B	2.69B	3.53B	2.55B	4.60B	3.37B	2.49B
Accounts Receivable	25.23B	23.87B	20.91B	18.63B	18.39B	14.30B	12.39B	11.31B
Inventory	20.49B	19.00B	17.45B	17.09B	15.37B	12.59B	11.06B	11.92B
Total Assets	76.59B	67.10B	62.56B	56.56B	57.34B	44.27B	39.17B	37.67B
Property, Plant & Equipment	4.09B	3.32B	3.15B	3.08B	3.23B	1.93B	1.77B	1.89B
Goodwill	13.68B	9.32B	9.57B	8.50B	9.03B	6.71B	6.71B	6.66B
Intangible Assets	3.77B	4.00B	4.43B	4.33B	5.26B	1.89B	2.29B	2.95B
Long-Term Investments	0.00	66.64M	63.12M	60.37M	0.00	0.00	-1.86B	0.00
Total Current Liabilities	57.82B	54.28B	48.83B	43.48B	41.36B	33.85B	29.58B	27.87B
Accounts Payable	54.72B	50.94B	45.84B	40.19B	38.01B	31.71B	28.39B	26.84B
Short-Term Debt	371.56M	781.10M	823.81M	1.23B	475.56M	593.85M	139.01M	151.66M
Total Liabilities	74.84B	66.31B	61.89B	56.49B	56.75B	45.11B	36.47B	34.97B
Long-Term Debt	8.96B	4.84B	5.07B	5.50B	7.33B	4.00B	4.03B	4.16B
Total Debt	10.75B	6.65B	6.82B	7.59B	8.75B	4.98B	4.49B	4.66B
Net Debt (Cash)	6.35B	3.42B	4.13B	4.06B	6.20B	385.38M	1.12B	2.17B
Total Shareholders' Equity	1.51B	645.94M	522.00M	-211.56M	223.35M	-1.02B	2.88B	2.93B
Common Stock	2.97M	2.96M	2.95M	2.93M	2.91M	2.88M	2.85M	2.84M
Retained Earnings	6.53B	5.42B	4.32B	2.98B	1.67B	518.34M	4.24B	3.72B
Current Ratio	0.90	0.88	0.88	0.91	0.94	0.98	0.95	0.93
Debt to Equity Ratio	7.13	10.30	13.06	-35.87	39.18	-4.89	1.56	1.59

Annual Report

09/30/2025

09/30/2024

09/30/2023

09/30/2022

09/30/2021

09/30/2020

09/30/2019

09/30/2018

Total Current Assets

52.24B

47.72B

42.80B

39.59B

38.80B

33.02B

28.13B

25.89B

Cash & Cash Equivalents

4.39B

3.23B

2.69B

3.53B

2.55B

4.60B

3.37B

2.49B

Short-Term Investments

0.00

Cash & Short-Term Investments

4.39B

3.23B

2.69B

3.53B

2.55B

4.60B

3.37B

2.49B

Accounts Receivable

25.23B

23.87B

20.91B

18.63B

18.39B

14.30B

12.39B

11.31B

Inventory

20.49B

19.00B

17.45B

17.09B

15.37B

12.59B

11.06B

11.92B

Total Assets

76.59B

67.10B

62.56B

56.56B

57.34B

44.27B

39.17B

37.67B

Property, Plant & Equipment

4.09B

3.32B

3.15B

3.08B

3.23B

1.93B

1.77B

1.89B

Goodwill

13.68B

9.32B

9.57B

8.50B

9.03B

6.71B

6.66B

Intangible Assets

3.77B

4.00B

4.43B

4.33B

5.26B

1.89B

2.29B

2.95B

Long-Term Investments

0.00

66.64M

63.12M

60.37M

0.00

-1.86B

0.00

Total Current Liabilities

57.82B

54.28B

48.83B

43.48B

41.36B

33.85B

29.58B

27.87B

Accounts Payable

54.72B

50.94B

45.84B

40.19B

38.01B

31.71B

28.39B

26.84B

Short-Term Debt

371.56M

781.10M

823.81M

1.23B

475.56M

593.85M

139.01M

151.66M

Total Liabilities

74.84B

66.31B

61.89B

56.49B

56.75B

45.11B

36.47B

34.97B

Long-Term Debt

8.96B

4.84B

5.07B

5.50B

7.33B

4.00B

4.03B

4.16B

Total Debt

10.75B

6.65B

6.82B

7.59B

8.75B

4.98B

4.49B

4.66B

Net Debt (Cash)

6.35B

3.42B

4.13B

4.06B

6.20B

385.38M

1.12B

2.17B

Total Shareholders' Equity

1.51B

645.94M

522.00M

-211.56M

223.35M

-1.02B

2.88B

2.93B

Common Stock

2.97M

2.96M

2.95M

2.93M

2.91M

2.88M

2.85M

2.84M

Retained Earnings

6.53B

5.42B

4.32B

2.98B

1.67B

518.34M

4.24B

3.72B

Current Ratio

0.90

0.88

0.91

0.94

0.98

0.95

0.93

Debt to Equity Ratio

7.13

10.30

13.06

-35.87

39.18

-4.89

1.56

1.59

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)